Steven L. Basta

This profile gathers the share dealings of Steven L. Basta across 4 companies, led by Yarrow Bioscience, Inc., Phathom Pharmaceuticals, Inc. and KalVista Pharmaceuticals, Inc. The record holds 18 filings, for trades running from 21 November 2016 to 10 February 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 12 February 2026, the filings show a share grant in Phathom Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.